Ignite Creation Date:
2025-12-25 @ 1:08 AM
Ignite Modification Date:
2026-02-20 @ 4:45 PM
Study NCT ID:
NCT03315793
Status:
COMPLETED
Last Update Posted:
2021-01-05
First Post:
2017-10-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder
Sponsor:
Shionogi
Organization:
Study Overview
Official Title:
A Double-blind, Efficacy and Safety Study of Duloxetine Hydrochloride Versus Placebo in the Treatment of Japanese Children and Adolescents With Depressive Disorder
Status:
COMPLETED
Status Verified Date:
2020-12-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the efficacy of duloxetine hydrochloride versus placebo in the treatment of Japanese children and adolescents with depressive disorder.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?: